EUVIMEDEUVIMED entdecken
Crossref

In Situ Self‐Assembly of Artificial Topological Nanostructures Enhances In Vivo Efficacy of PCSK9 Inhibitory Peptides

Qin Li, Zhaode Mu, Yuhan Dong, Zubin Ouyang, Jianli Zuo, Yijie Wu, Yuxuan Yang, Si Sun, Hongwen Liang iD, Lijuan Bai

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202502559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Qin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chongqing Medical University, Chongqing Research Center for Pharmaceutical Engineering, 1 Yixueyuan Road, Yuzhong District, Chon…. Hauptthemen laut MEDLINE: Nanostructures, Proprotein Convertase 9, Peptides, PCSK9 Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Natural Science Foundation, Scientific and Technological Research Program of Chongqing Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimizing the stability and affinity of peptides in vivo is critical for their development as alternatives to approved monoclonal antibodies. In recent years, efforts in academia and industry have focused on modifying Pep2‐8, a classical antagonistic peptide targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), to enhance its specificity and affinity. However, developing effective PCSK9 inhibitory peptides remains challenging, especially given the limited examples of their successful in vivo applications. Here, we designed transformable inhibitory peptide (TIP) against PCSK9 based on the modular structure of Pep2‐8. Upon encountering PCSK9, TIP undergoes in situ self‐assembly at the epidermal growth factor‐like domain A (EGF‐A) binding domain of PCSK9 to form artificial topological nanostructures (ATNs). The ATNs not only enhance peptide stability and prolong in vivo retention time but also strengthen PCSK9 binding through multivalent synergistic effects. We demonstrate that compared to Pep2‐8, TIP forms ATNs which increasing its binding affinity for PCSK9 by approximately 18.7‐fold in vitro. In high‐fat diet mouse models, TIP significantly increase hepatic LDLR levels (2.0‐fold) and reduced LDL‐C and TC levels. We envision that the in situ formation of ATNs by peptides enhances in vivo stability and affinity, which offering an approach for development as antibody alternatives in clinical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanostructuresProprotein Convertase 9PeptidesPCSK9 InhibitorsAnimalsMiceHumans

Stichwörter der Autor:innen

PCSK9hypercholesterolemiananostructurepeptideself-assembly

Substanzen

Proprotein Convertase 9PeptidesPCSK9 InhibitorsPCSK9 protein, human

Autor:innen und Institutionen

  • College of Pharmacy, Chongqing Medical University, Chongqing Research Center for Pharmaceutical Engineering, 1 Yixueyuan Road, Yuzhong District, Chongqing, China.
  • Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, China.
  • National Engineering Research Center of Immunological Products, Third Military Medical University, 30 Gaotanyan Zheng Street, Shapingba District, Chongqing, China.

ORCID-Profile: Hongwen Liang

Förderung

  • National Natural Science Foundation of China
  • Chongqing Natural Science Foundation
  • Scientific and Technological Research Program of Chongqing Municipal Education Commission
  • Chongqing Municipal Education Commission
  • China Postdoctoral Science Foundation
  • Open Competition for Key Research Projects

Zitieren

APA

Li, Q., Mu, Z., Dong, Y., Ouyang, Z., Zuo, J., Wu, Y., Yang, Y., Sun, S., Liang, H., & Bai, L. (2025). In Situ Self‐Assembly of Artificial Topological Nanostructures Enhances In Vivo Efficacy of PCSK9 Inhibitory Peptides. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202502559

Vancouver

Li Q, Mu Z, Dong Y, Ouyang Z, Zuo J, Wu Y, et al. In Situ Self‐Assembly of Artificial Topological Nanostructures Enhances In Vivo Efficacy of PCSK9 Inhibitory Peptides. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202502559

BibTeX
@article{Li2025,
  author = {Li, Qin and Mu, Zhaode and Dong, Yuhan and Ouyang, Zubin and Zuo, Jianli and Wu, Yijie and Yang, Yuxuan and Sun, Si and Liang, Hongwen and Bai, Lijuan},
  title = {In Situ Self‐Assembly of Artificial Topological Nanostructures Enhances In Vivo Efficacy of PCSK9 Inhibitory Peptides},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202502559}
}
Kostenlos starten →